Industry Trends

International research institutions continued to make important progress in probiotic research and clinical regulation, providing new perspectives for the development of next-generation probiotics.

Akkermansia muciniphila: Potential and Complexity

Scientists from Luxembourg Institute of Health published a review in *Nature Microbiology* on Akkermansia muciniphila as next-generation probiotic. And the key points were:

- Found in about 40% of healthy individuals worldwide.

- Might support metabolic health, especially in obesity people.

- Effects varied due to diet, gut microbiota, genetics, and health conditions.

- Different strains affected immunity and the intestinal barrier differently.

Researchers called for deeper characterisation before therapeutic use and strategies to maximise benefits while reducing risks.

UCLA Probiotic and Obesity Study

UCLA received a US$4 million NIH grant to study whether specific probiotic combinations affected the gut-microbiome-brain network in obese adults. And the study details were:

- Five-year PROBE study with around 250 obese participants.

- By randomised, double-blind and placebo-controlled design.

- Used high-field MRI to examine brain pathways linked to reward, motivation, food craving, and eating behaviour.

The study aimed to identify biomarkers to predict the responses for targeted microbiome interventions, supporting more personalised obesity prevention and treatment.

Website-Friendly Closing Statement

Next-generation probiotics held promise but their success depended on strain-specific evidence, careful characterisation, and personalised application.